New combo therapy could help Hard-to-Treat liver patients
NCT ID NCT06591468
First seen Jan 06, 2026 · Last updated May 08, 2026 · Updated 23 times
Summary
This study looks at whether adding the steroid prednisone to the standard medicine UDCA can help people with a liver disease called primary biliary cholangitis (PBC) who have a specific type of liver inflammation. About 244 adults will take part. The goal is to see if the combination improves liver function and reduces symptoms like itching and tiredness, while checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS (PBC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China
-
Xijing hospital
Xi'an, Shaanxi, 710032, China
Conditions
Explore the condition pages connected to this study.